Navigation Links
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
Date:5/21/2008

HILDEN, Germany, May 21 /PRNewswire-FirstCall/ --

- Research Supports Replacement of Pap With HPV Test as Front-line Screen

Long-term data from a study published in the International Journal of Cancer show that women screened only with a human papillomavirus (HPV) DNA test are half as likely to develop moderate to severe cervical disease over the next six years as those who get only conventional cytology (the Pap "smear"). The research followed nearly 3,000 women age 35 years and older, and assessed their HPV status using QIAGEN's digene(R) HPV Test - the only such test that is both CE-marked in Europe and approved by the U.S. Food and Drug Administration (FDA).

"These results confirm that HPV DNA testing identifies more women with disease than the Pap," says Professor Jack Cuzick, lead author of the May 15 article and professor of epidemiology at the Wolfson Institute of Preventive Medicine, affiliated with Queen Mary's School of Medicine and Dentistry in London. "They add further support to the proposal to use HPV testing as the sole primary screen in women age 35 or older, when the risk of cervical cancer is highest."

Participants were recruited into the study from April 1994 to September 1997 at 40 different general-medicine practices in the United Kingdom. A colposcopy exam and biopsy were used to confirm or rule out the presence of cervical disease after each woman had both the HPV test and a conventional Pap. The sensitivity of the digene HPV Test was 96 percent for disease detected in the first year - substantially higher than the Pap's 82.4 percent. In addition to the HPV test's greater ability to accurately identify women with pre-cancerous cervical cells or cancer, its specificity (the likelihood that women with positive results actually have disease) was similar to that of the Pap.

Study results also showed that the women's risk of developing cervical abnormalities in the future were significantly less when they
'/>"/>

SOURCE Qiagen N V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
3. Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds
4. Study Analyzed SYMBICORT(R) in Children with Persistent Asthma
5. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
8. Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
9. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
10. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
11. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...raphyEquipment-AGlobalMarketPerspective ,, h...uipment---A-Global-Market-Perspective.html ,, ...lasdevelopingnationsisaprincipalfactorinfluencingg...renessaboutbreastcancerhasallowedwomentocomeforwar...
(Date:11/25/2009)...wire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amed...imallydisruptivesurgicaltreatmentsforthespine,anno...vember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferenc...ntfortheCompany,sproductsandwillincludecommentsfro...n.Thedial-innumbersare1-877-407-4018fordomesticcal...
(Date:11/25/2009)...dJOHANNESBURG,November25/PRNewswire/--,iThembaPhar...cedtoday,thattheyhavesignedacollaborativeagreement...is,sworldclasscomputationalchemistryandleaddiscove...iontoprovidemedicinaland,syntheticchemistrysupport...entnetwork.iThembaPharmaceuticalsandPyxisDiscovery...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Congressional Health Care Reform Proposals Would Make Health Care More Expensive Reduce Benefits for Louisianians 61843 1Congressional Health Care Reform Proposals Would Make Health Care More Expensive Reduce Benefits for Louisianians 61843 2AAFPRS Opposes the Proposed Tax on Medical Procedures 61838 1AAFPRS Opposes the Proposed Tax on Medical Procedures 61838 2Genetic analysis helps dissect molecular basis of cardiovascular disease 10845 1Genetic analysis helps dissect molecular basis of cardiovascular disease 10845 2
... YORK, July 28 Polyphenon Pharma, an emerging,res...d that the Food and,Drug Administration (FDA) has ...rug, Polyphenon E(R), for the treatment of chronic...urrently underway at the Mayo Clinic,in Rochester,...cts of an,oral daily dose of Polyphenon E in CLL p...
...NTAIN VIEW, Calif., July 24 Alexza,Pharmaceutical...as initiated,its second Phase 3 clinical trial wit...lation product candidate being developed for the t...ophrenia or bipolar disorder.,Alexza believes the ...ic,(PK) properties resulting from inhaled loxapine...
Other Medicine Technology:Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6
(Date:11/27/2009)...BC,Nov.27/PRNewswire/-UploadableUSBpedometersmaybe...mbinationofadvancedaccelerometerfunctionalityandau...accuracyofself-reporteddata.It,snowpossibletoaccur...program. ,, CoreHealthTechnologiesisoneofthefir...ealthchallengesareeasytoadministerandparticipatein...
(Date:11/27/2009)...ISCO,Nov.27/PRNewswire-FirstCall/--TheGymboreeCorp...O/COO,willpresentattheNASDAQOMX23rdInvestorProgram...onWednesday,December2,2009,at11:45a.m.GMT. ,, T...resentationovertheInternet,pleaselogontowww.gymbor...o"InvestorandMediaRelations"andthen"ConferenceCall...
(Date:11/27/2009)...HAMIR,Israel,Nov.27/PRNewswire-FirstCall/--ShamirO...dingproviderofinnovativeproductsandtechnologytothe...irectorshaddeclaredadividenddistributioninanaggreg...onbasedontheNovember25,2009representativerateofexc...basedontheNovember25,2009representativerateofexcha...
(Date:11/27/2009)... bring unprecedented medical, economic burdens, st...Day News) -- The number of people with diabetes in...next 25 years, a new study predicts. , That wou...eople with the disease, up from 23.7 million today...ple with diabetes will triple, the study also warn...
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...the July 9 issue of Archives of Internal Medicine,...ific antigen (PSA) tests to screen for prostate ca...hom the PSA test is not shown to be beneficial, an...ot recommend routine PSA screening for men younger...
...ished in the July 10, 2007, issue of Neurology, th...logy , People with early Parkinsons disease report...g of hallucinations, sleepiness, and swelling. ...r Kevin Biglan, MD, MPH, with University of Roches...
...n Wednesday lamented opposition from several state...from next year, a report said . "In our co...it and that is why we have a billion population," ...wareness among our children," he was quoted as say...
...s top luxury hotel chains called on the country We...ities or suffer a drop in tourist arrivals . ...rists," said P.R.S. Oberoi, the chairman of the EI...leaning up our cities must happen," he told report...
...rida neuroscientist reports that the cutting-edge ...h Parkinsons disease is compelling on several fron...heir job of easing disease symptoms. Paul R. ...eural Stem Cells for Parkinsons Disease: To Protec...
...n low and middle-income countries can turn out eco...conclusion was reached by A UCSF-led team of rese...ms underway in countries like India, South Africa,... With the recent report from the Global HIV Preven...
Other Medicine News:Health News:Clinicians Ordering Inappropriate Prostate Screenings 2Health News:Early Parkinsons Show Hallucination,sleepiness 2Health News:Stem Cells Research in Parkinsons Disease 2Health News:HIV Prevention Programs on a Massive Scale Turn Out Economical 2
Irrigating Cystotome, Formed, 23 g
Peribulbar Needle, 25 g. Atkinson style bevel.
Scleral Blade tip 5700 style, straight
Blade Tip Handle
Medicine Products: